<DOC>
	<DOCNO>NCT02610374</DOCNO>
	<brief_summary>The primary objective ass effect short-term diet modification microbiome composition , inflammatory/metabolic disease marker Antiretroviral therapy ( ART ) -treated HIV-infected participant Human immunodeficiency virus ( HIV ) -negative control United States .</brief_summary>
	<brief_title>Diet / Gut Microbiome Interaction Influence Inflammatory Disease HIV Patients</brief_title>
	<detailed_description>This randomize clinical trial . Fifty ( 50 ) Antiretroviral therapy ( ART ) -treated Human immunodeficiency virus ( HIV ) positive participant , 24 HIV negative control match age sex , 24 HIV negative control population high risk contract HIV recruit 3 cohort . All participant undergo 4 week diet modification randomly assign receive either Agrarian diet Western-type diet . For first 2 week , food provide participant , follow additional 2 week participant provide diet menu recipe prepare . There 4 study visit participation last 2 month .</detailed_description>
	<criteria>HIVinfected cohort ( Cohort A ) Documentation HIV1 infection define positive antibody test plasma HIV1 RNA ( ribosomal ribonucleic acid ) . Treated ART ( minimum three antiretroviral drug regimen ) least 12 month change antiretroviral drug past 6 month Plasma HIV1 RNA ≤ 50 copies/mL precede 6 month . HIVnegative cohort ( Cohort B C ) Documentation negative HIV1 antibody test All Cohorts Age 18 65 year Body mass index 2129 kg/m2 ( nonobese ) Stable weight least 3 month ( ≤15 % change body weight ) Negative pregnancy test ( female ) Use systemic ( oral parenteral ) antibiotic within two month prior study entry Active chronic infection hepatitis B C active malignancy require systemic chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Gut microbiota composition</keyword>
</DOC>